Paperboy Ventures is a US-based venture capital firm that focuses on investing in startup consumer packaged goods (CPG) companies. The firm typically participates in later-stage investment rounds, including Series D, Series E, and post-IPO equity, indicating a preference for more mature startups with proven business models and growth potential.
Notable portfolio companies include Corcept Therapeutics and Microbia, which have raised substantial funds of $10.1 million and $115 million, respectively. Paperboy Ventures is known for its strategic investment philosophy and provides unique value-add services to its portfolio companies, leveraging extensive industry expertise and a robust network to drive growth and success.
Portfolio Snapshot
Recorded participation and recipient operating status, not current holdings or realized exits
Top Investment Stages
Stage Mix
Concentration shown as share of disclosed investments by stage.
Classification
- Also Known As
- Paperboy Ventures, LLC
- NAICS
- 520000Finance and Insurance
- 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
- 523900Other Financial Investment Activities
- 523990All Other Financial Investment Activities
- 523999Miscellaneous Financial Investment Activities
- SIC
- 6700Holding And Other Investment Offices
- 6790Miscellaneous Investing
- 6799Investors, Not Elsewhere Classified
- Industry
- —Financial Services Companies
- —Investment Companies
- —Investment Management Companies
- —Private Equity Firms
- —Venture Capital Firms
Show 6 more industry codes
- NAICS
- 525000Funds, Trusts, and Other Financial Vehicles
- 523910Miscellaneous Intermediation
- 523940Portfolio Management and Investment Advice
- SIC
- 6000Depository Institutions
- 6720Investment Offices
- 6722Management Investment Offices, Open-end
